Escondido, CA, United States of America

Dan Arenson

This inventor holds 1 USPTO granted patent. Top assignee: Pp Holdings Inc.. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dan Arenson

Introduction

Dan Arenson is a notable inventor based in Escondido, California. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent. His work focuses on enhancing the administration of drugs, which can greatly impact patient care and treatment efficacy.

Latest Patents

Dan Arenson holds a patent for a transdermal delivery system designed for the modulated administration of drugs. This system includes a backing, a drug reservoir containing the drug, a plasticizer-type enhancer, a solvent-type enhancer, and optionally, a gelling agent. Additionally, it features a non-rate-controlling membrane and an adhesive layer containing a plasticizer-type enhancer. This innovative drug delivery system is particularly useful for the administration of tolerance-inducing drugs, such as vasodilators like isosorbide dinitrate.

Career Highlights

Arenson's career is marked by his dedication to improving drug delivery methods. His work at Pp Holdings Inc. has allowed him to focus on developing advanced technologies that enhance the effectiveness of drug administration. His patent reflects his commitment to innovation in the healthcare sector.

Collaborations

Dan Arenson has collaborated with notable professionals in his field, including William R. Pfister and Frank Kochinke. These collaborations have contributed to the development and refinement of his innovative drug delivery systems.

Conclusion

Dan Arenson's contributions to the field of drug delivery systems exemplify the impact of innovation in healthcare. His patent for a transdermal delivery system showcases his commitment to improving patient treatment options. Through his work, he continues to influence the future of drug administration technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…